biotechnology sectors. As part of Baxalta, they have access to additional expertise in product research, development, manufacturing, and commercialization to their work with entrepreneurs.

Baxalta Ventures believe that establishing strong relationships with entrepreneurs, other venture capital investors, and industry experts is critical for the long-term success of their portfolio companies. They aim to accelerate and enhance commercialization activities in portfolio companies by creating strategic alliances with other venture capital funds and by leveraging Baxalta’s expertise in clinical development, production, and marketing of therapeutic solutions. Baxalta Ventures is managed by an experienced leadership team with extensive expertise in venture capital, scientific innovation, and operational leadership in the healthcare industry. Their initial investments are generally up to $5 million and may increase throughout the life of the company.